Strategic Partnerships ACP is actively expanding its AI collaboration footprint through partnerships with Biostate AI to develop RNA sequencing based models for predicting MS progression and treatment response, highlighting opportunities to position complementary data analytics, AI model development, and data-sharing services to enhance joint research outcomes.

Data Driven With iConquerMS linking 10,000+ people affected by MS and one of the world’s largest MS biospecimen collections, there is a strong foundation for selling data enrichment, patient engagement platforms, and biospecimen access management solutions to enable more inclusive and rigorous research.

Clinical AI Recent news shows ACP launching AI caregiving tools and AI models for progression prediction, creating a market for healthcare AI solutions, care partner support tech, and integration services that connect AI insights with patient care workflows.

Fundraising & Growth As a non-profit with substantial annual revenue, ACP may seek technology, analytics, and fundraising platforms that optimize grant tracking, donor management, and impact reporting to sustain growth and broaden research capabilities.

Thought Leadership Active publication of AI and RNA sequencing initiatives positions ACP as a leader in MS research innovation, suggesting collaboration opportunities for sponsored research programs, co-branded studies, and pilot projects with pharma/biotech partners focused on precision medicine in MS.